AUTL

Autolus Therapeutics

68 hedge funds and large institutions have $260M invested in Autolus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

6% more funds holding

Funds holding: 6468 (+4)

1.95% more ownership

Funds ownership: 61.22%63.17% (+1.9%)

Holders
68
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$341K
Puts
$17K
Net Calls
Net Calls Change

Top Buyers

1 +$21.9M
2 +$4.76M
3 +$3.78M
4
ECM
ExodusPoint Capital Management
New York
+$866K
5
Two Sigma Investments
Two Sigma Investments
New York
+$513K

Top Sellers

1 -$8.14M
2 -$5.73M
3 -$3.28M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$1.05M
5
Millennium Management
Millennium Management
New York
-$663K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$50.8M
2
$48.8M
3
$35.7M
4
$28.6M
5
$21.9M
6
$17.3M
7
$10.2M
8
$8.92M
9
$4.75M
10
$3.98M
11
$3.78M
12
$3.57M
13
$2.21M
14
$2.07M
15
$1.85M
16
$1.66M
17
$1.57M
18
$1.31M
19
$1.26M
20
$1.24M
21
$956K
22
$933K
23
$735K
24
$619K
25
$582K